Need Help? Call 1­-866-­796-­7386
« back to stock screener

  CBAY stock: CymaBay Therapeutics Inc

Current Rating
Strong Sell

Previous Rating

Strong Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$8.66
Market Cap
535.5M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
2.81
P/S
101.39
Dividend %
-
P/CF
23.0
P/FCF
-
Op. Cash Flow
-41.4K
FCF
-
Op. Margin
-
Net Margin
-
ROE
-34.00%
ROI
-23.40%
ROA
-30.70%
EPS Growth
-2.90%
Current Ratio
6.3
Debt/Equity
3.50%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
InfuSystem Holdings Inc (INFU) $3.41 - - 66.6M Strong Buy
Bausch Health Companies Inc (BHC) $22.87 - - 8.31B Strong Buy
Stereotaxis Inc (STXS) $1.37 - - 79.7M Strong Buy
BioScrip Inc (BIOS) $3.85 - - 499.4M Strong Buy
DENTSPLY SIRONA Inc (XRAY) $36.97 - 0.90% 8.23B Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More